Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for kids with rare Muscle-Weakening disease

NCT ID NCT06607627

Recruiting now Disease control Sponsor: Alexion Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a drug called gefurulimab in children and teenagers (ages 6 to 18) who have generalized myasthenia gravis, a condition that causes severe muscle weakness. The main goals are to see how the drug moves through the body, if it is safe, and if it helps reduce symptoms like difficulty walking, talking, or swallowing. This is not a cure; it is a treatment aimed at controlling the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Research Site

    RECRUITING

    Norfolk, Virginia, 23507, United States

  • Research Site

    RECRUITING

    Joinville, 89202-451, Brazil

  • Research Site

    RECRUITING

    Salvador, 41253-190, Brazil

  • Research Site

    RECRUITING

    São José do Rio Preto, 15090-000, Brazil

  • Research Site

    RECRUITING

    São Paulo, 0438-002, Brazil

  • Research Site

    RECRUITING

    São Paulo, 05403-000, Brazil

  • Research Site

    RECRUITING

    Saitama-Shi, 330-8777, Japan

  • Research Site

    WITHDRAWN

    Bydgoszcz, 85-065, Poland

  • Research Site

    WITHDRAWN

    Lodz, 93-338, Poland

  • Research Site

    RECRUITING

    Warsaw, 02-097, Poland

  • Research Site

    RECRUITING

    New Taipei City, 23561, Taiwan

  • Research Site

    RECRUITING

    Taipei, 11101, Taiwan

Conditions

Explore the condition pages connected to this study.

GENERALIZED MYASTHENIA GRAVIS GMG